MEN1 and Zollinger-Ellison syndrome: Type 2 gastric carcinoids develop at an increased rate in MEN1/ZES patients because of the presence of chronic hypergastrinemia combined with the molecular effects of the presence of the MEN1 gene mutations (Figure 6A).